Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Possibly Marketed Outside US

2

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

2011

1

2016

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Structurally Diverse

2

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

DRUG BANK

2

FDA UNII

2

NCI_THESAURUS

2

NDF-RT

2

ChEMBL

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

MUSCULO-SKELETAL SYSTEM

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Other drugs for disorders of the musculo-skeletal system

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

2

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Established Pharmacologic Class [EPC]|Autologous Cultured Cell [EPC]" in comments (approximate match)

Showing 1 - 2 of 2 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

AUTOLOGOUS CULTURED CHONDROCYTES

D5P3K3V822

Status:

Possibly Marketed Outside US

First approved in 2016

Class:

STRUCTURALLY DIVERSE

AZFICEL-T

022461SR75

Status:

Possibly Marketed Outside US

First approved in 2011

Class:

STRUCTURALLY DIVERSE

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1